Allogeneic Anti-CD7 CAR-T for Type 1 Diabetes

Clinical trial NCT07528105 · RECRUITING

Trial details

NCT number: NCT07528105
Sponsor: Shanghai Zhongshan Hospital
Status: RECRUITING
Phase: Early Phase 1
Study type: INTERVENTIONAL

T1DM - Type 1 Diabetes Mellitus

Start date: 2026-04-01
Primary completion: 2027-12-01
Enrollment: 9

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.